期刊文献+

双氯灭痛栓和曲马多治疗晚期肝癌疼痛的比较 被引量:3

COMPARISON OF DICLOFENAC SUPPOSITORY AND TRAMADOL FOR ADVANCED LIVER CANCER PAIN
下载PDF
导出
摘要 目的 比较双氯灭痛栓与曲马多对晚期肝癌疼痛的镇痛效果。方法  5 2例晚期肝癌重度疼痛病人 (男性 4 3例 ,女性 9例。年龄 2 8~ 81岁 ,平均年龄 5 6 .8岁 )。随机分为双氯灭痛栓组 (双氯灭痛栓 10 0 mg,塞入肛门内 5 cm ,q12 h)和曲马多组 (曲马多 10 0 mg,肌注 ,q12 h) ,两组各用药 4天 ,再交换用药 4天。结果 双氯灭痛栓组止痛作用优于曲马多组 ,总有效率分别为 92 .31%和 76 .92 %(P<0 .0 5 )。双氯灭痛栓组平均镇痛有效持续时间为 10 .4± 4 .7h,优于曲马多组 7.2± 3.1h(P<0 .0 0 1)。两组不良反应发生率无差异。结论 双氯灭痛栓治疗晚期肝癌疼痛疗效满意 。 Objective To compare the clinical efficacy of diclofenac suppository and tramadol in the treatment of advanced liver cancer pain.Methods Fifty-two advanced liver cancer patients(M43,F9,age ranging from 28 to 81 years,mean age was 56.8 years)suffering from severe pain,were randomly divided into 2 groups:Diclofenac suppository(100 mg,rectal medication,q12 h) and tramadol(100 mg,im q12 h)groups.Twenty six patients received diclofenac suppository in first 4 day and tramadol in next 4 day,while another 26 patients received tramadol first 4 day and diclofenac suppository in the next 4 day.Results The pain-relief effective rate in diclofenac suppository group was 92.31%,higher than those(76.92%) of tramadol group(p<0.05).The pain-relief lasting-time in diclofenac suppository group was 92.31%,higher than those(76.92%) of tramadol group(p<0.05).The pain-relief lasting -time in diclofenac suppository group was 10.4±4.7 h,longer than those(7.2±3.1 h)of tramadol group(p<0.001).The adverse reactions were not much different between two groups(P>0.05).Conclusion The efficacy of diclofenac suppository in treating advanced liver cancer pain is satisfactory and superiority to tramadol.It could be the first choice in the control of severe liver cancer pain.
出处 《肝胆外科杂志》 2002年第3期210-211,共2页 Journal of Hepatobiliary Surgery
关键词 双氯灭痛栓 曲马多 癌痛 晚期肝癌 Diclofenac Suppository Tramadol Cancer pain
  • 相关文献

参考文献2

共引文献50

同被引文献13

  • 1马春清,方长明,邓辉,叶昶.双氯灭痛栓治疗肾绞痛1680例[J].中国中西医结合急救杂志,2005,12(5):278-278. 被引量:2
  • 2张孝文,李源,张革化,刘贤,杨钦泰,黄健聪.鼻及鼻窦手术后的镇痛[J].中国耳鼻咽喉头颈外科,2006,13(12):829-832. 被引量:6
  • 3Appel-Dingemanse S,Hirschberg Y,Oslborne S,et al.Multiple-dose pharmacokinetics confirm no accumulation and dose proportionality of the novel promotile drug tegaserod (HTF 919)[J].Eur J Clin Pharmacol,2001,56(12):889.
  • 4Haq A,Patel HR,Habib MR,et al.Diclofenac suppository analgesia for transrectal ultrasound guided biopsies of the prostate:a double-blind,randomized controlled trial[J].J Urol,2004,171(4):1489.
  • 5Hewitt PG,Poblete N,Wester RC,et al.In vitro cutaneous disposition of a topical diclofenac lotion in human skin:effect of a multi-dose regimen[J].Pharm Res,1998,15(7):988.
  • 6Terhaag B,Heffmann A,Bankworth M,et al.Bioavailability of a new effervescent tablet of diclofenac[J].Int J Clin Pharmacol Ther,2000,38(11):546.
  • 7Haq A, Patel HR, Habib MR, et al. Diclofenac suppository analgesia for transrectal ultrasound guided biopsies of the prostate: a double-blind, randomized controlled trial[J]. JUrol, 2004, 171(4): 1489-1491.
  • 8Avgerinos A, Karidas T, Malamataris S. Extractionless highperformance liquid chromatographic method for the determination of diclofenac in human plasma and urine[J]. JChromatogr, 1993, 619(2): 324-329.
  • 9Gonzalez L, Yuln G, Volonte MG. Determination of cyanocobalamin, betamethasone, and diclofenac sodium in pharmaceutical formulations, by high performance liquid chromatography[J]. J Pharm Biomed Anal, 1999, 20(3):487-492.
  • 10Lee HS, Jeong CK, Choi S J, et al. Simultaneous determination of aceclofenac and diclofenac in human plasma by narrowbore HPLC using column-switching[J]. J Pharm Biomed Anal,2000, 23(5): 775-781.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部